Vedere
Cambridge, US · 1 known investors
Vedere Bio develops optogenetics-based gene therapies for inherited retinal diseases (IRDs) and geographic atrophy (GA), using proprietary AAV vectors for intravitreal administration to restore vision in visually impaired patients globally.
BiotechDeep TechMedical Devices
Founders & leadership
Sf
Scientific founders at University of California, Berkeley